Indicators for assessing folate and vitamin B12 status and for monitoring the efficacy of intervention strategies

Food and Nutrition Bulletin

Volumn 29, Issue 2 SUPPL., 2008, Pages

  Green, Ralph ^a  

^a University of Illinois School of Medicine   (United States)

Author keywords

Clinical laboratory measurement; Cobalamin; Erythrocyte folate; Homocysteine; Methylmalonate; Nutritional assessment; Plasma folate; Transcobalamin; Vitamin B12

Indexed keywords

CONFERENCE PROCEEDING; MORBIDITY; NUTRITIONAL STATUS; VITAMIN; VITAMIN DEFICIENCY;

EID: 48249152199     PISSN: 03795721     EISSN: None     Source Type: Journal    
DOI: 10.1177/15648265080292s108     Document Type: Conference Paper

References (72)

1. Green R, Miller JW. Folate deficiency beyond megaloblastic anemia: Hyperhomocysteinemia and other manifestations of dysfunctional folate status. Semin Hematol 1999;36:47-64.
2. Carmel R. Current concepts in cobalamin deficiency. Annu Rev Med 2000;51:357-75.
3. Lynch S, Green R. Assessment of nutritional anemias. In: Ramakrishnan U, ed. Nutritional anemias. Boca Raton, Fla, USA: CRC Press, 2000:23-42.
4. Hoffbrand V, Green R. Megaloblastic anaemia. In: Hoffbrand V, Catovsky D, Tuddenham E, eds. Post-graduate haematology. Malden, MA USA: Blackwell Publishing, 2005:60-84.
5. Green R. Metabolite assays in cobalamin and folate deficiency. Baillieres Clin Haematol 1995;8:533-66.
6. Carmel R, Green R, Rosenblatt DS, Watkins D. Update on cobalamin, folate, and homocysteine. Hematology Am Soc Hematol Educ Program 2003: 62-81.
7. 12 or folate deficiency does not translate into a comparable prevalence of anemia. Food Nutr Bull 2008: 29:S74-85.
8. 12) and folate deficiency. FASEB J 1993;7:1344-53.
9. Hvas AM and Nexo E. Holotranscobalamin - a first choice assay for diagnosing early vitamin B deficiency? J Intern Med 2005;257:289-98.
10. 12 deficiency. Clin Chem 2003;49:2076-8.
11. 12 deficiency and determination of holotranscobalamin in populations at risk. Clin Chem Lab Med 2003;41:1478-88.
12. 12 deficiency. Clin Chem 2006;52:278-85.
13. 12 in serum evaluated. Clin Chem 1994; 40:537-40.
14. Lindenbaum J, Savage DG, Stabler SP, Allen RH. Diagnosis of cobalamin deficiency: II. Relative sensitivities of serum cobalamin, methylmalonic acid, and total homocysteine concentrations. Am J Hematol 1990; 34:99-107.
15. Lindenbaum J, Rosenberg IH, Wilson PW, Stabler SP, Allen RH. Prevalence of cobalamin deficiency in the Framingham elderly population. Am J Clin Nutr 1994;60:2-11.
16. Solomon LR. Cobalamin-responsive disorders in the ambulatory care setting: Unreliability of cobalamin, methylmalonic acid, and homocysteine testing. Blood 2005;105:978-85.
17. Green R. Unreliability of current assays to detect cobalamin deficiency: "Nothing gold can stay". Blood 2005;105;910-1.
18. Stabler SP, Allen RH, Savage DG, Lindenbaum J. Clinical spectrum and diagnosis of cobalamin deficiency. Blood 1990;76:871-81.
19. 12 metabolism. Br J Haematol 1971;20:511-20.
20. Green R: Typical and atypical manifestations of pernicious anemia. In: Bhatt HR, James VHT, Besser GM, Bottazzo GF, Keen H, eds. Advances in Thomas Addison's diseases. Bristol, UK: Journal of Endocrinology 1994;1:377-390.
21. 12 balance. Lab Invest 1988; 58:332-7.
22. Carmel R. Mild transcobalamin I (haptocorrin) deficiency and low serum cobalamin concentrations. Clin Chem 2003;49:1367-74.
23. O'Broin SD, Kelleher BP, Davoren A, Gunter EW. Field-study screening of blood folate concentrations: Specimen stability and finger-stick sampling. Am J Clin Nutr 1997;66:1398-405.
24. O'Broin SD, Gunter EW. Screening of folate status with use of dried blood spots on filter paper. Am J Clin Nutr 1999;70:359-67.
25. Herbert V. Experimental nutritional folate deficiency in man. Trans Assoc Am Physicians 1962;75:307-20.
26. Selhub J, Jacques PF, Wilson PW, Rush D, Rosenberg IH. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA 1993;270:2693-8.
27. Halsted CH, Villanueva J, Chandler CJ, Stabler SP, Allen RH, Muskhelishvili L, James SJ, Poirier L. Ethanol feeding of micropigs alters methionine metabolism and increases hepatocellular apoptosis and proliferation. Hepatology 1996;23:497-505.
28. Hoffbrand AV, Newcombe FA, Mollin DL. Method of assay of red cell folate activity and the value of the assay as a test for folate deficiency. J Clin Pathol 1966;19:17-28.
29. Tamura T, Soong SJ, Sauberlich HE, Hatch KD, Cole P, Butterworth CE Jr. Evaluation of the deoxyuridine suppression test by using whole blood samples from folic acid-supplemented subjects. Am J Clin Nutr 1990;51:80-6.
30. 12/folate kit. Clin Chem 1993;39:2209-10.
31. Carmel R, Brar S, Agrawal A, Penha PD. Failure of assay to identify low cobalamin concentrations. Clin Chem 2000;46:2017-8.
32. Pfeiffer CM, Caudill SP, Gunter EW, Osterloh J, Sampson EJ. Biochemical indicators of B vitamin status in the US population after folic acid fortification: Results from the National Health and Nutrition Examination Survey 1999-2000. Am J Clin Nutr 2005;82:442-50.
33. Dueker SR, Lin Y, Jones AD, Mercer R, Fabbro E, Miller JW, Green R, Clifford AJ. Determination of blood folate using acid extraction and internally standardized gas chromatography-mass spectrometry detection. Anal Biochem 2000;283:266-75.
34. Owen WE, Roberts WL. Comparison of five automated serum and whole blood folate assays. Am J Clin Pathol 2003;120:121-6.
35. Benesch RE, Benesch R, Kwong S, Baugh CM. A pteroylpolyglutamate binds to tetramers in deoxyhemoglobin but to dimers in oxyhemoglobin. Proc Natl Acad Sci USA 1983;80:6202-5.
36. Wright AJ, Finglas PM, Southon S. Erythrocyte folate analysis: A cause for concern? Clin Chem 1998; 44:1886-91.
37. Molloy AM, Daly S, Mills JL, Kirke PN, Whitehead AS, Ramsbottom D, Conley MR, Weir DG, Scott JM. Thermolabile variant of 5,10-methylenetetrahydrofolate reductase associated with low red-cell folates: Implications for folate intake recommendations. Lancet 1997;349:1591-3.
38. Nelen WL, Blom HJ, Thomas CM, Steegers EA, Boers GH, Eskes TK. Methylenetetrahydrofolate reductase polymorphism affects the change in homocysteine and folate concentrations resulting from low dose folic acid supplementation in women with unexplained recurrent miscarriages. J Nutr 1998;128:1336-41.
39. Guinotte CL, Burns MG, Axume JA, Hata H, Urrutia TF, Alamilla A, McCabe D, Singgih A, Cogger EA, Caudill MA. Methylenetetrahydrofolate reductase 677C→T variant modulates folate status response to controlled folate intakes in young women. J Nutr 2003;133:1272-80.
40. Pereira AC, Schettert IT, Morandini Filho AA, Guerra-Shinohara EM, Krieger JE. Methylenetetrahydrofolate reductase (MTHFR) c677t gene variant modulates the homocysteine folate correlation in a mild folate-deficient population. Clin Chim Acta 2004;340:99-105.
41. 12 status in healthy older adults. Blood 2002;100:718-20. Erratum in: Blood 2002; 100:3483.
42. Wans S, Schuttler K, Jakubiczka S, Muller A, Luley C, Dierkes J. Analysis of the transcobalamin II 776C→G (259P>R) single nucleotide polymorphism by denaturing HPLC in healthy elderly: Associations with cobalamin, homocysteine and holo-transcobalamin II. Clin Chem Lab Med 2003;41:1532-6.
43. 12 metabolism. Am J Clin Nutr 2005;81:1436-41.
44. 12 deficiency: Caveat emptor. Ann Intern Med 1996;124:509-11
45. Refsum H, Smith AD, Ueland PM, Nexo E, Clarke R, McPartlin J, Johnston C, Engbaek F, Schneede J, McPartlin C, Scott JM.. Facts and recommendations about total homocysteine determinations: An expert opinion. Clin Chem 2004;50:3-32.
46. McCann SJ, Gillingwater S, Keevil BG, Cooper DP, Morris MR. Measurement of total homocysteine in plasma and blood spots using liquid chromatography-tandem mass spectrometry: Comparison with the plasma Abbott IMx method. Ann Clin Biochem 2003;40:161-5.
47. Rusin O, St Luce NN, Agbaria RA, Escobedo JO, Jiang S, Warner IM, Dawan FB, Lian K, Strongin RM. Visual detection of cysteine and homocysteine. J Am Chem Soc 2004;126:438-9.
48. Selhub J, Miller JW. The pathogenesis of homocysteinemia: Interruption of the coordinate regulation by S-adenosylmethionine of the remethylation and transsulfuration of homocysteine. Am J Clin Nutr 1992;55:131-8.
49. McLean RR, Jacques PF, Selhub J, Tucker KL, Samelson EJ, Broe KE, Hannan MT, Cupples LA, Kiel DP. Homocysteine as a predictive factor for hip fracture in older persons. N Engl J Med 2004;350:2042-9.
50. van Meurs JB, Dhonukshe-Rutten RA, Pluijm SM, van der Klift M, de Jonge R, Lindemans J, de Groot LC, Hofman A, Witteman JC, van Leeuwen JP, Breteler MM, Lips P, Pols HA, Uitterlinden AG. Homocysteine levels and the risk of osteoporotic fracture. N Engl J Med 2004;350:2033-41.
51. 12 status relate to bone turnover markers, broadband ultrasound attenuation, and fractures in healthy elderly people. J Bone Miner Res 2005;20:921-9.
52. McCaddon A, Davies G, Hudson P, Tandy S, Cattell H. Total serum homocysteine in senile dementia of Alzheimer type. Int J Geriatr Psychiatry 1998;13:235-9.
53. Seshadri S, Beiser A, Selhub J, Jacques PF, Rosenberg IH, D'Agostino RB, Wilson PW, Wolf PA. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med 2002;346:476-83.
54. Mudd SH, Brosnan JT, Brosnan ME, Jacobs RL, Stabler SP, Allen RH, Vance DE, Wagner C. Methyl balance and transmethylation fluxes in humans. Am J Clin Nutr 2007;85:19-25.
55. Liaugaudas G, Jacques PF, Selhub J, Rosenberg IH, Bostom AG. Renal insufficiency, vitamin B(12) status, and population attributable risk for mild hyperhomocysteinemia among coronary artery disease patients in the era of folic acid-fortified cereal grain flour. Arterioscler Thromb Vasc Biol 2001;21:849-51.
56. 12 deficiency is the dominant nutritional cause of hyperhomocysteinemia in a folic acid-fortified population. Clin Chem Lab Med 2005;43:1048-51.
57. 12 status. Food Nutr Bull 2008;29:S67-73.
58. Boushey CJ, Beresford SA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 1995;274:1049-57.
59. Christen WG, Ridker PM. Blood levels of homocysteine and atherosclerotic vascular disease. Curr Atheroscler Rep 2000;2:194-9.
60. Marcell PD, Stabler SP, Podell ER, Allen RH. Quantitation of methylmalonic acid and other dicarboxylic acids in normal serum and urine using capillary gas chromatography-mass spectrometry. Anal Biochem 1985;150:58-66.
61. Rasmussen K. Solid-phase sample extraction for rapid determination of methylmalonic acid in serum and urine by a stable-isotope-dilution method. Clin Chem 1989;35:260-4.
62. Kushnir MM, Komaromy-Hiller G, Shushan B, Urry FM, Roberts WL. Analysis of dicarboxylic acids by tandem mass spectrometry. High-throughput quantitative measurement of methylmalonic acid in serum, plasma, and urine. Clin Chem 2001;47:1993-2002.
63. Rasmussen K. Studies on methylmalonic acid in humans. I. Concentrations in serum and urinary excretion in normal subjects after feeding and during fasting, and after loading with protein, fat, sugar, isoleucine, and valine. Clin Chem 1989;35:2271-6.
64. Moelby L, Rasmussen K, Rasmussen HH. Serum methylmalonic acid in uraemia. Scand J Clin Lab Invest 1992;52:351-4.
65. 12) deficiency detection by urinary methylmalonic acid quantitation. Blood 1982;59:1128-31.
66. McCann MT, Thompson MM, Gueron IC, Lemieux B, Giguere R, Tuchman M. Methylmalonic acid quantification by stable isotope dilution gas chromatography-mass spectrometry from filter paper urine samples. Clin Chem 1996 Jun;42(6 pt 1):910-4.
67. Ulleland M, Eilertsen I, Quadros EV, Rothenberg SP, Fedosov SN, Sundrehagen E, Orning L. Direct assay for cobalamin bound to transcobalamin (holo-transcobalamin) in serum. Clin Chem 2002;48:526-32.
68. Orning L, Rian A, Campbell A, Brady J, Fedosov SN, Bramlage B, Thompson K, Quadros EV. Characterization of a monoclonal antibody with specificity for holotranscobalamin. Nutr Metab (Lond) 2006;3:3.
69. Nexo E, Hvas AM, Bleie O, Refsum H, Fedosov SN, Vollset SE, Schneede J, Nordrehaug JE, Ueland PM, Nygard OK. Holo-transcobalamin is an early marker of changes in cobalamin homeostasis: A randomized placebo-controlled study. Clin Chem 2002;48:1768-71.
70. 12 status. Clin Chem Lab Med 2003;41: 1489-92.
71. 12 deficiency and determination of holotranscobalamin in populations at risk. Clin Chem Lab Med 2003; 41:1478-88.
72. 12 status in the elderly as judged by available biochemical markers. Clin Chem 2004;50:238-41.